Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study (Q30612910)

25 June 2017

title

Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study (English)

1 reference

25 June 2017

1 reference

Désirée van der Heijde

3

object named as

Désirée van der Heijde

0 references

Tore K. Kvien

9

object named as

Tore K Kvien

1 reference

25 June 2017

Karen Minde Fagerli

1

1 reference

25 June 2017

Elisabeth Lie

2

1 reference

25 June 2017

Marte Schrumpf Heiberg

4

1 reference

25 June 2017

Synøve Kalstad

5

1 reference

25 June 2017

Erik Rødevand

6

1 reference

25 June 2017

Knut Mikkelsen

7

1 reference

25 June 2017

Ase Stavland Lexberg

8

1 reference

25 June 2017

language of work or name

English

0 references

publication date

5 April 2013

1 reference

Annals of the Rheumatic Diseases

25 June 2017

published in

1 reference

25 June 2017

volume

72

1 reference

25 June 2017

issue

11

1 reference

25 June 2017

page(s)

1840-1844

1 reference

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203018

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203018

Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203018

Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203018

Sustained response to long-term biologics and switching in psoriatic arthritis: results from real life experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203018

Switching tumour necrosis factor alpha antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203018

Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203018

Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203018

Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203018

Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203018

Effectiveness of switching between TNF inhibitors in ankylosing spondylitis: data from the NOR-DMARD register

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203018

The estimation of a preference-based measure of health from the SF-36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203018

Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203018

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-203018

10.1136/ANNRHEUMDIS-2012-203018

21 January 2018

Identifiers

DOI

1 reference

25 June 2017

1 reference